119th CONGRESS 1st Session
To reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
- (a) Short title
- This Act may be cited as the SUPPORT for Patients and Communities Reauthorization Act of 2025.
- (b) Table of contents
Section 317L(d) of the Public Health Service Act () is amended by striking such sums as may be necessary for each of the fiscal years 2019 through 2023and inserting $4,250,000 for each of fiscal years 2026 through 2030. 42 U.S.C. 247b–13(d)
Section 317N(d) of the Public Health Service Act () is amended by striking fiscal years 2019 through 2023and inserting fiscal years 2026 through 2030. 42 U.S.C. 247b–15(d)
- (a) In general
- Section 392A of the Public Health Service Act () is amended— 42 U.S.C. 280b–1
- in subsection (a)(2)—
- in subparagraph (C), by inserting before the period at the end; and
- in subparagraph (D), by striking
opioidsand inserting substances causing overdose; and
- in subsection (b)(2)—
- in subparagraph (B), by inserting after ;
- in subparagraph (C), by striking
codingand inserting monitoring and identifying;
- in subparagraph (E)—
- (i) by inserting a comma after ; and
- (ii) by inserting after ; and
- in subparagraph (F), by inserting after .
- (b) Additional grants
- Section 392A(a)(3) of the Public Health Service Act () is amended— 42 U.S.C. 280b–1(a)(3)
- in the matter preceding subparagraph (A), by striking
and Indian Tribes—and inserting and Indian Tribes for the following purposes:;
- To carry out innovative projects for grantees to detect, identify, and rapidly respond to controlled substance misuse, abuse, and overdoses, and associated risk factors, including changes in patterns of such controlled substance use. Such projects may include the use of innovative, evidence-based strategies for detecting such patterns, such as wastewater surveillance, if proven to support actionable prevention strategies, in a manner consistent with applicable Federal and State privacy laws.
- by amending subparagraph (A) to read as follows:
- in subparagraph (B), by striking
for anyand inserting For any.
- (c) Authorization of appropriations
- Section 392A(e) of the Public Health Service Act () is amended by striking
$496,000,000 for each of fiscal years 2019 through 2023and inserting $505,579,000 for each of fiscal years 2026 through 2030. 42 U.S.C. 280b–1(e)
- (a) In general
- Part O of title III of the Public Health Service Act () is amended to read as follows: 42 U.S.C. 280f et seq.
- (a) In general
- The Secretary shall establish or continue activities to support a comprehensive fetal alcohol spectrum disorders (referred to in this section as ) education, prevention, identification, intervention, and services delivery program, which may include—
FASD
- an education and public awareness program to support, conduct, and evaluate the effectiveness of—
- educational programs targeting health professions schools, social and other supportive services, educators and counselors and other service providers in all phases of childhood development, and other relevant service providers, concerning the prevention, identification, and provision of services for infants, children, adolescents, and adults with FASD;
- strategies to educate school-age children, including pregnant and high-risk youth, concerning FASD;
- public and community awareness programs concerning FASD; and
- strategies to coordinate information and services across affected community agencies, including agencies providing social services such as foster care, adoption, and social work, agencies providing health services, and agencies involved in education, vocational training, and civil and criminal justice;
- supporting and conducting research on FASD, as appropriate, including to—
- develop appropriate medical diagnostic methods for identifying FASD; and
- develop effective culturally and linguistically appropriate evidence-based or evidence-informed interventions and appropriate supports for preventing prenatal alcohol exposure, which may co-occur with exposure to other substances;
- building State and Tribal capacity for the identification, treatment, and support of individuals with FASD and their families, which may include—
- utilizing and adapting existing Federal, State, or Tribal programs to include FASD identification and FASD-informed support;
- developing and expanding screening and diagnostic capacity for FASD;
- developing, implementing, and evaluating targeted FASD-informed intervention programs for FASD;
- providing training with respect to FASD for professionals across relevant sectors; and
- disseminating information about FASD and support services to affected individuals and their families; and
- an applied research program concerning intervention and prevention to support and conduct service demonstration projects, clinical studies and other research models providing advocacy, educational and vocational training, counseling, medical and mental health, and other supportive services, as well as models that integrate and coordinate such services, that are aimed at the unique challenges facing individuals with fetal alcohol spectrum disorder or fetal alcohol effect and their families.
Section 399O(h) of the Public Health Service Act () is amended by adding at the end the following: 42 U.S.C. 280g–3(h)
- (5) Promoting state choice
- Nothing in this section shall be construed to authorize the Secretary to require States to use a specific vendor or a specific interoperability connection other than to align with nationally recognized, consensus-based open standards, such as in accordance with sections 3001 and 3004.
Section 546 of the Public Health Service Act () is amended— 42 U.S.C. 290ee–1
- in subsection (a), by striking
tribes and tribaland inserting Tribes and Tribal;
- in subsections (a), (c), and (d)—
- by striking each place it appears and inserting
approved, cleared, or otherwise legally marketed; and
- by striking each place it appears;
- in subsection (f)—
- by striking each place it appears and inserting
approved, cleared, or otherwise legally marketed;
- in paragraph (1), by striking ;
- in paragraph (2)—
- (i) by striking
opioid and heroinand inserting opioid, heroin, and other drug; and
- (ii) by striking
opioid overdoseand inserting overdose; and
- in paragraph (3), by striking ; and
- in subsection (h), by striking
$36,000,000 for each of fiscal years 2019 through 2023and inserting $57,000,000 for each of fiscal years 2026 through 2030.
- (a) Technical amendment
- The second part G of title V of the Public Health Service Act (), as added by section 144 of the Community Renewal Tax Relief Act of 2000 (), is amended— 42 U.S.C. 290kk et seq.; Public Law 106–554
- by redesignating such part as part J; and
- by redesignating sections 581 through 584 as sections 596 through 596C, respectively.
- (b) In general
- Section 582 of the Public Health Service Act () is amended— 42 U.S.C. 290hh–1
- in the section heading, by striking and inserting ;
- in subsection (a)—
- in the matter preceding paragraph (1), by striking
tribes and tribaland inserting Tribes and Tribal; and
- in paragraph (2), by inserting after ;
- in subsection (b), by inserting after ;
- in subsection (d)—
- by striking and inserting the following:
- (1) Coordinating center
- (2) NCTSI grantees
- In carrying out subsection (a)(2), NCTSI grantees shall develop trainings and other resources, as applicable and appropriate, to support implementation of the evidence-based practices developed and disseminated under such subsection.
- by adding at the end the following:
- in subsection (e)—
- by redesignating paragraphs (1) and (2) as subparagraphs (A) and (B), respectively, and adjusting the margins accordingly;
- in subparagraph (A), as so redesignated, by inserting after ;
- by striking and inserting the following:
- (1) Coordinating center
- (2) NCTSI grantees
- NCTSI grantees shall, as appropriate, collaborate with other such grantees, the NCTSI coordinating center, and the Secretary in carrying out subsections (a)(2) and (d)(2).
- by adding at the end the following:
- (h) Application and evaluation
- To be eligible to receive a grant, contract, or cooperative agreement under subsection (a), a public or nonprofit private entity or an Indian Tribe or Tribal organization shall submit to the Secretary an application at such time, in such manner, and containing such information and assurances as the Secretary may require, including—
- a plan for the evaluation of the activities funded under the grant, contract, or agreement, including both process and outcomes evaluation, and the submission of an evaluation at the end of the project period; and
- a description of how such entity, Indian Tribe, or Tribal organization will support efforts led by the Secretary or the NCTSI coordinating center, as applicable, to evaluate activities carried out under this section.
- (a) National suicide prevention lifeline program
- Section 520E–3(b) of the Public Health Service Act (42 U.S.C. 290bb–36c(b)) is amended—
- in paragraph (4), by striking
and at the end;
- in paragraph (5), by striking the period at the end and inserting
; and; and
- taking such steps as may be necessary to ensure the suicide prevention hotline is protected from cybersecurity incidents and eliminates known cybersecurity vulnerabilities.
- by adding at the end the following:
- (b) Reporting
- Section 520E–3 of the Public Health Service Act () is amended— 42 U.S.C. 290bb–36c
- by redesignating subsection (f) as subsection (g); and
- (f) Cybersecurity reporting
- (1) Notification
- (A) In general
- The program’s network administrator receiving Federal funding pursuant to subsection (a) shall report to the Assistant Secretary, in a manner that protects personal privacy, consistent with applicable Federal and State privacy laws—
- (i) any identified cybersecurity vulnerabilities to the program within a reasonable amount of time after identification of such a vulnerability; and
- (ii) any identified cybersecurity incidents to the program within a reasonable amount of time after identification of such incident.
- (B) Local and regional crisis centers
- Local and regional crisis centers participating in the program shall report to the program’s network administrator identified under subparagraph (A), in a manner that protects personal privacy, consistent with applicable Federal and State privacy laws—
- (i) any identified cybersecurity vulnerabilities to the program within a reasonable amount of time after identification of such vulnerability; and
- (ii) any identified cybersecurity incidents to the program within a reasonable amount of time after identification of such incident.
- (2) Notification
- If the program’s network administrator receiving funding pursuant to subsection (a) discovers, or is informed by a local or regional crisis center pursuant to paragraph (1)(B) of, a cybersecurity vulnerability or incident, within a reasonable amount of time after such discovery or receipt of information, such entity shall report the vulnerability or incident to the Assistant Secretary.
- (3) Clarification
- (A) Oversight
- (i) Except as provided in clause (ii), local and regional crisis centers participating in the program shall oversee all technology each center employs in the provision of services as a participant in the program.
- (ii) The program’s network administrator receiving Federal funding pursuant to subsection (a) shall oversee the technology each crisis center employs in the provision of services as a participant in the program if such oversight responsibilities are established in the applicable network participation agreement.
Section 7131(e) of the SUPPORT for Patients and Communities Act () is amended by striking ,000,000 for each of fiscal years 2019 through 2023and inserting $9,000,000 for each of fiscal years 2026 through 2030. 42 U.S.C. 242t(e)
- (a) Youth prevention and recovery
- Section 7102(c) of the SUPPORT for Patients and Communities Act (42 U.S.C. 290bb–7a(c)) is amended—
- in paragraph (3)(A)(i), by inserting before the semicolon; and
- in paragraph (4)(A), by inserting before the semicolon.
- (b) Interdepartmental substance use disorders coordinating committee
- Section 7022 of the SUPPORT for Patients and Communities Act ( note) is amended— 42 U.S.C. 290aa
- (g) Working groups
- (1) In general
- The Committee may establish working groups for purposes of carrying out the duties described in subsection (e). Any such working group shall be composed of members of the Committee (or the designees of such members) and may hold such meetings as are necessary to carry out the duties delegated to the working group.
- (2) Additional federal interagency work group on fentanyl contamination of illegal drugs
- (A) Establishment
- The Secretary, acting through the Committee, shall establish a Federal Interagency
Work Group on Fentanyl Contamination of Illegal Drugs (referred to in this paragraph as the ) consisting of representatives from relevant Federal departments and agencies on the Committee.
- (B) Consultation
- The Work Group shall consult with relevant stakeholders and subject matter experts, including—
- (i) State, Tribal, and local subject matter experts in reducing, preventing, and responding to drug overdose caused by fentanyl contamination of illicit drugs; and
- (ii) family members of both adults and youth who have overdosed by fentanyl contaminated illicit drugs.
- (C) Duties
- The Work Group shall—
- (i) examine Federal efforts to reduce and prevent drug overdose by fentanyl-contaminated illicit drugs;
- (ii) identify strategies to improve State, Tribal, and local responses to overdose by fentanyl-contaminated illicit drugs;
- (iii) coordinate with the Secretary, as appropriate, in carrying out activities to raise public awareness of synthetic opioids and other emerging drug use and misuse issues;
- (iv) make recommendations to Congress for improving Federal programs, including with respect to the coordination of efforts across such programs; and
- (v) make recommendations for educating youth on the potency and dangers of drugs contaminated by fentanyl.
- (D) Annual report to secretary
- The Work Group shall annually prepare and submit to the Secretary, the Committee on Health, Education, Labor, and Pensions of the Senate, and the Committee on Energy and Commerce and the Committee on Education and Workforce of the House of Representatives, a report on the activities carried out by the Work Group under subparagraph (C), including recommendations to reduce and prevent drug overdose by fentanyl contamination of illegal drugs, in all populations, and specifically among youth at risk for substance misuse.
- (a) In general
- Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, shall publish guidance to facilitate the use of at-home safe disposal systems for applicable drugs.
- (b) Contents
- The guidance under subsection (a) shall include—
- recommended standards for effective at-home drug disposal systems to meet applicable requirements enforced by the Food and Drug Administration;
- recommended information to include as instructions for use to disseminate with at-home drug disposal systems;
- best practices and educational tools to support the use of an at-home drug disposal system, as appropriate; and
- recommended use of licensed health providers for the dissemination of education, instruction, and at-home drug disposal systems, as appropriate.
- (a) In general
- Not later than one year after the date of enactment of this Act, the
Secretary of Health and Human Services (referred to in this section as the ) shall publish on the website of the Food and Drug Administration (referred to in this section as the ) a report that outlines a plan for assessing opioid analgesic drugs that are approved under section 505 of the Federal Food, Drug, and Cosmetic Act () that addresses the public health effects of such opioid analgesic drugs as part of the benefit-risk assessment and the activities of the FDA that relate to facilitating the development of nonaddictive medical products intended to treat pain or addiction. Such report shall include— 21 U.S.C. 355
- an update on the actions taken by the FDA to consider the effectiveness, safety, benefit-risk profile, and use of approved opioid analgesic drugs;
- a timeline for an assessment of the potential need, as appropriate, for labeling changes, revised or additional postmarketing requirements, enforcement actions, or withdrawals for opioid analgesic drugs;
- an overview of the steps that the FDA has taken to support the development and approval of nonaddictive medical products intended to treat pain or addiction, and actions planned to further support the development and approval of such products; and
- an overview of the consideration by the FDA of clinical trial methodologies for analgesic drugs, including the enriched enrollment randomized withdrawal methodology, and the benefits and drawbacks associated with different trial methodologies for such drugs, incorporating any public input received under subsection (b).
- (b) Public input
- In carrying out subsection (a), the Secretary shall provide an opportunity for public input concerning the regulation by the FDA of opioid analgesic drugs, including scientific evidence that relates to conditions of use, safety, or benefit-risk assessment (including consideration of the public health effects) of such opioid analgesic drugs.
The activities carried out pursuant to section 1003(b)(4)(A) of the 21st Century Cures Act (42 U.S.C. 290ee–3a(b)(4)(A)) may include facilitating access to products used to prevent overdose deaths by detecting the presence of one or more substances, such as fentanyl and xylazine test strips, to the extent the purchase and possession of such products is consistent with Federal and State law.
Section 508 of the Public Health Service Act () is amended— 42 U.S.C. 290bb–1
- in subsection (d)(11)(C), by striking
providing health servicesand inserting providing health care services;
- in subsection (g)—
- by inserting after ; and
- by adding at the end the following: ; and
Such plan may include a description of how such applicant will target outreach to women disproportionately impacted by maternal substance use disorder.
- in subsection (s), by striking
9,931,000 for each of fiscal years 2019 through 2023and inserting $38,931,000 for each of fiscal years 2026 through 2030.
Section 597 of the Public Health Service Act () is amended— 42 U.S.C. 290ll
- in subsection (a)(1), by inserting after ; and
- in subsection (b), by inserting after .
Section 756(f) of the Public Health Service Act () is amended by striking fiscal years 2023 through 2027and inserting fiscal years 2026 through 2030. 42 U.S.C. 294e–1(f)
Section 781(j) of the Public Health Service Act () is amended by striking 5,000,000 for each of fiscal years 2019 through 2023and inserting $40,000,000 for each of fiscal years 2026 through 2030. 42 U.S.C. 295h(j)
Section 7053 of the SUPPORT for Patients and Communities Act ( note) is amended by striking subsection (e). 42 U.S.C. 290dd–2
Section 7132 of the SUPPORT for Patients and Communities Act (; 132 Stat. 4046) is amended— Public Law 115–271
- in subsection (b)(1)—
- by redesignating subparagraph (CC) as subparagraph (DD); and
- The Administration for Community Living.
- by inserting after subparagraph (BB) the following:
- in subsection (d)(1), in the matter preceding subparagraph (A), by inserting before ; and
- in subsection (i), by striking and inserting .
Section 3203 of the SUPPORT for Patients and Communities Act ( note) is amended— 21 U.S.C. 823
- by striking subsection (b); and
- by striking and inserting the following: .
- (a) Review of use of certain funding
- Not later than 1 year after the date of enactment of this Act, the
Secretary of Health and Human Services (referred to in this section as the ), acting through the Assistant Secretary for Mental Health and Substance Use, shall conduct a review of State use of funds made available under the Community Mental Health Services Block Grant program under subpart I of part B of title XIX of the Public Health Service Act () (referred to in this section as the ) for first episode psychosis activities. Such review shall consider the following: block grant program 42 U.S.C. 300x et seq.
- How States use funds for evidence-based treatments and services according to the standard of care for individuals with early serious mental illness and children with a serious emotional disturbance.
- The percentages of the State funding under the block grant program expended on early serious mental illness and first episode psychosis, and the number of individuals served under such funds.
- (b) Report and guidance
- (1) Report
- Not later than 180 days after the completion of the review under subsection (a), the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate and the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives a report describing—
- the findings of the review under subsection (a); and
- any recommendations for changes to the block grant program that would facilitate improved outcomes for individuals with serious mental illness and children with serious emotional disturbance.
- (2) Guidance
- Not later than 1 year after the date on which the report is submitted under paragraph (1), the Secretary shall update the guidance provided to States under the block grant program on coordinated specialty care and other evidence-based mental health care services for individuals with serious mental illness and children with a serious emotional disturbance, based on the findings and recommendations of such report.
- (a) Secretary of HHS
- The Secretary of Health and Human Services shall, consistent with the requirements and procedures set forth in sections 201 and 202 of the Controlled Substances Act (, 812)— 21 U.S.C. 811
- review the relevant data pertaining to the scheduling of products containing a combination of buprenorphine and naloxone that have been approved under section 505 of the Federal Food, Drug, and Cosmetic Act (); and 21 U.S.C. 355
- if appropriate, request that the Attorney General initiate rulemaking proceedings to revise the schedules accordingly with respect to such products.
- (b) Attorney General
- The Attorney General shall review any request made by the Secretary of Health and Human Services under subsection (a)(2) and determine whether to initiate proceedings to revise the schedules in accordance with the criteria set forth in sections 201 and 202 of the Controlled Substances Act (, 812). 21 U.S.C. 811
- (a) In general
- The Secretary of Health and Human Services shall ensure that, as appropriate, whenever the Department of Health and Human Services issues a regulation or guidance for any grant program addressing opioid misuse and use disorders, any reference to an opioid overdose reversal drug (such as a reference to naloxone) is inclusive of any opioid overdose reversal drug that has been approved under section 505 of the Federal Food, Drug, and Cosmetic Act () for emergency treatment of a known or suspected opioid overdose. 21 U.S.C. 355
- (b) Existing references
- (1) Update
- Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services shall update all references described in paragraph (2) to be inclusive of any opioid overdose reversal drug that has been approved or otherwise authorized for use by the Food and Drug Administration.
- (2) References
- A reference described in this paragraph is any reference to an opioid overdose reversal drug (such as naloxone) in any regulation or guidance of the Department of Health and Human Services that—
- was issued before the date of enactment of this Act; and
- is included in—
- (i) the grant program for State and Tribal response to opioid use disorders under section 1003 of the 21st Century Cures Act ( note) (commonly referred to as and ); or
State Opioid Response Grants Tribal Opioid Response Grants 42 U.S.C. 290ee–3
- (ii) the grant program for priority substance use disorder prevention needs of regional and national significance under section 516 of the Public Health Service Act (). 42 U.S.C. 290bb–22
- (a) Roundtable
- Not later than 180 days after the date of enactment of this Act, the National Coordinator for Health Information Technology shall convene a public roundtable to examine—
- how the expanded use of electronic health records among mental health and substance use service providers can improve outcomes for patients in mental health and substance use settings; and
- how best to increase electronic health record adoption among such providers.
- (b) Participants
- The National Coordinator for Health Information Technology shall ensure that the participants in the roundtable under subsection (a) include private and public sector stakeholders, including patients, providers (including providers of inpatient services and providers of outpatient services), and representatives of payors, health information exchanges, professional associations, health information technology vendors, health information technology certification organizations, and State and Federal agencies.
- (c) Report
- Not later than 180 days after the conclusion of the public stakeholder roundtable under subsection (a), the National Coordinator for Health Information Technology shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report outlining information gathered from the roundtable under subsection (a). Such report shall include an examination of—
- recommendations from the roundtable participants;
- unique considerations for using electronic health record systems in mental health and substance use treatment settings;
- unique considerations for developers of health information technology relating to certification of electronic health record systems for use in mental health and substance use treatment settings where the applicable health information technology is not subject to certification requirements;
- current usage of electronic health record systems by mental health and substance use disorder service providers, and the scope and magnitude of such providers that do not use electronic health record systems;
- examples of how electronic health record systems enable coordinated care and care management;
- how electronic health record systems advance appropriate patient and provider access to secure, usable electronic information exchange;
- how electronic health record systems can be connected to or support existing systems, which may include the 9–8–8 National Suicide Prevention Lifeline, mobile crisis response systems, and co-responder programs, to facilitate connectivity, response, and integrated care;
- any existing programs to support greater adoption of electronic health record systems among mental health and substance use service providers;
- any limitations to greater adoption of electronic health record systems among mental health and substance use service providers;
Section 547(f) of the Public Health Service Act () is amended by striking $5,000,000 for each of fiscal years 2019 through 2023and inserting inserting7,000,000 for each of fiscal years 2026 through 2030. 42 U.S.C. 290ee–2(f)
Section 547A of the Public Health Service Act () is amended— 42 U.S.C. 290ee–2a
- in subsection (b)(4), by striking and inserting the following:
- building, such as—
- professional development of peer support specialists; and
- making recovery support services available in nonclinical settings; and
- by redesignating subsections (d) and (e) as subsections (e) and (f), respectively;
- (d) Regional centers
- (1) In general
- The Secretary may establish one regional technical assistance center (referred to in this subsection as the ), with existing resources, to assist the Center in carrying out activities described in subsection (b) within the geographic region of such
Regional Center in a manner that is tailored to the needs of such region.
- (2) Evaluation
- Not later than 4 years after the date of enactment of the , the Secretary shall evaluate the activities of the Regional Center and submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on the findings of such evaluation, including—
- a description of the distinct roles and responsibilities of the Regional Center and the Center;
- available information relating to the outcomes of the Regional Center under this subsection, such as any impact on the operations and efficiency of the Center relating to requests for technical assistance and support within the region of such Regional Center;
- a description of any gaps or areas of duplication relating to the activities of the Regional Center and the Center within such region; and
- recommendations relating to the modification, expansion, or termination of the Regional Center under this subsection.
- (3) Termination
- This subsection shall terminate on September 30, 2030.
- by inserting after subsection (c) the following:
- in subsection (f), as so redesignated, by striking
striking,000,000 for each of fiscal years 2019 through 2023and inserting ,000,000 for each of fiscal years 2026 through 2030.
Section 552 of the Public Health Service Act () is amended— 42 U.S.C. 290ee–7
- in subsection (d)(2)—
- in the matter preceding subparagraph (A), by striking
and in such mannerand inserting , in such manner, and containing such information and assurances, including relevant documentation,; and
- in subparagraph (A), by striking
is capable of coordinating with other entities to carry outand inserting has the demonstrated capability to carry out, through referral or contractual arrangements;
- in subsection (h)—
- by redesignating paragraphs (1) through (4) as subparagraphs (A) through (D), respectively, and adjusting the margins accordingly;
- by striking and inserting the following:
- (1) In general
- (2) Additional reporting for certain eligible entities
- An entity carrying out activities described in subsection (g) through referral or contractual arrangements shall include in the submissions required under paragraph (1) information related to the status of such referrals or contractual arrangements, including an assessment of whether such referrals or contractual arrangements are supporting the ability of such entity to carry out such activities.
- by adding at the end the following:
- in subsection (j), by striking
2019 through 2023and inserting 2026 through 2030.
Section 7102(c) of the SUPPORT for Patients and Communities Act (42 U.S.C. 290bb–7a(c)) (as amended by section 110(a)) is amended—
- in paragraph (2)—
- in subparagraph (A)—
- (i) in clause (i)—
- by inserting after ; and
- by striking
high schoolsand inserting secondary schools; and
- (ii) in clause (vi), by striking
tribe, or tribaland inserting Tribe, or Tribal;
- (E) Indian tribe; tribal organization
- The terms and have the meanings given such terms in section 4 of the Indian Self-Determination and Education Assistance Act ().
Indian Tribe,Tribal organization 25 U.S.C. 5304
- by amending subparagraph (E) to read as follows:
- by redesignating subparagraph (K) as subparagraph (L); and
- (K) Secondary school
- The term
secondary school has the meaning given such term in section 8101 of the Elementary and Secondary Education Act of 1965 (). 20 U.S.C. 7801
- by inserting after subparagraph (J) the following:
- in paragraph (3)(A), in the matter preceding clause (i)—
- by striking ; and
- by inserting after ;
- in paragraph (4)—
- in the matter preceding subparagraph (A), by striking
Indian tribesand inserting Indian Tribes;
- in subparagraph (A), by striking ; and
- in subparagraph (B), by striking
peer mentoringand inserting peer-to-peer support;
- in paragraph (5), by striking
tribaland inserting Tribal;
- in paragraph (6)(A)—
- in clause (iv), by striking and inserting a semicolon
; and; and
- (vi) a plan to sustain the activities carried out under the grant program, after the grant program has ended; and
- by adding at the end the following:
- in paragraph (8), by striking and inserting ; and
- (9) Authorization of appropriations
- To carry out this subsection, there are authorized to be appropriated—
- $10,000,000 for fiscal year 2026;
- $12,000,000 for fiscal year 2027;
- $13,000,000 for fiscal year 2028;
- $14,000,000 for fiscal year 2029; and
- $15,000,000 for fiscal year 2030.
- by amending paragraph (9) to read as follows:
- (a) In general
- Section 7183 of the SUPPORT for Patients and Communities Act () is amended— 42 U.S.C. 290ee–8
- in the section heading, by inserting after ;
- in subsection (b), by inserting before ;
- in subsection (c)—
- in paragraph (1), by striking
the rates described in paragraph (2)and inserting the average rates for calendar years 2018 through 2022 described in paragraph (2); and
- (2) Rates
- The rates described in this paragraph are the following:
- The highest age-adjusted average rates of drug overdose deaths for calendar years 2018 through 2022 based on data from the Centers for Disease Control and Prevention, including, if necessary, provisional data for calendar year 2022.
- The highest average rates of unemployment for calendar years 2018 through 2022 based on data provided by the Bureau of Labor Statistics.
- The lowest average labor force participation rates for calendar years 2018 through 2022 based on data provided by the Bureau of Labor Statistics.
- by amending paragraph (2) to read as follows:
- in subsection (g)—
- in each of paragraphs (1) and (3), by redesignating subparagraphs (A) and (B) as clauses (i) and (ii), respectively, and adjusting the margins accordingly;
- by redesignating paragraphs (1) through (3) as subparagraphs (A) through (C), respectively, and adjusting the margins accordingly;
- in the matter preceding subparagraph (A) (as so redesignated), by striking and inserting the following:
- (1) In general
- (2) Transportation services
- An entity receiving a grant under this section may use not more than 5 percent of the funds for providing transportation for individuals to participate in an activity supported by a grant under this section, which transportation shall be to or from a place of work or a place where the individual is receiving vocational education or job training services or receiving services directly linked to treatment of or recovery from a substance use disorder.
- (3) Limitation
- The Secretary may not require an entity to, or give priority to an entity that plans to, use the funds of a grant under this section for activities that are not specified in this subsection.
- by adding at the end the following:
- in subsection (i)(2), by inserting after ;
- in subsection (j)—
- in paragraph (1), by inserting after ; and
- in paragraph (2)—
- (i) in the matter preceding subparagraph (A), by striking
2 years after submitting the preliminary report required under paragraph (1)and inserting ; and
Section 8041(g)(1) of the SUPPORT for Patients and Communities Act () is amended by striking and inserting . 29 U.S.C. 3225a(g)(1)
- (a) In general
- Not later than one year after the date of enactment of this Act, the
Secretary of Health and Human Services (referred to in this section as the ) shall convene a public meeting for purposes of improving awareness of, and access to, information related to current and future funding opportunities under programs administered by the Substance Abuse and Mental Health Services Administration (in this section referred to as ). SAMHSA funding opportunities
- (b) Topics
- The public meeting under subsection (a) shall include—
- opportunities to improve the utility and functionality of internet websites maintained by the Secretary that provide information related to SAMHSA funding opportunities, such as Grants.gov;
- other models for displaying and disseminating information related to SAMHSA funding opportunities, such as interactive dashboards; and
- strategies to improve the ability of entities to apply for SAMHSA funding opportunities, including entities that have not traditionally applied for SAMHSA funding opportunities.
- (c) Website improvements
- The Secretary shall implement improvements to Grants.gov related to SAMHSA funding opportunities based on stakeholder feedback received at the public meeting under subsection (a), as appropriate, to the maximum extent feasible.
- (d) Report
- Not later than one year after the date on which the public meeting under subsection (a) is convened, the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report summarizing the findings of such meeting, including how the Secretary has taken into account the feedback received through such meeting and implemented—
- improvements to internet websites maintained by the Secretary that provide information related to SAMHSA funding opportunities; and
- strategies to improve awareness of SAMHSA funding opportunities.
Section 309A(a) of the Controlled Substances Act () is amended by striking paragraph (2) and inserting the following: 21 U.S.C. 829a(a)
- the controlled substance is a drug in schedule III, IV, or V to be administered—
- by injection or implantation for the purpose of maintenance or detoxification treatment; or
- subject to a risk evaluation and mitigation strategy pursuant to section 505–1 of the Federal Food, Drug, and Cosmetic Act () that includes elements to assure safe use of the drug described in subsection (f)(3)(E) of such section, including a requirement for post-administration monitoring by a health care provider; 21 U.S.C. 355–1
- (a) In general
- Section 303 of the Controlled Substances Act () is amended— 21 U.S.C. 823
- by redesignating the second subsection designated as subsection (l) as subsection (m); and
- in subsection (m)(1), as so redesignated—
- in subparagraph (A)—
- (i) in clause (iv)—
- in subclause (I)—
- by inserting before ;
- by striking
or the Commissionand inserting , the Commission; and
- by inserting before the semicolon at the end; and
- in subclause (III), by inserting after ; and
- (ii) in clause (v), in the matter preceding subclause (I)—
- by striking
osteopathic medicine, dental surgeryand inserting osteopathic medicine, podiatric medicine, dental surgery; and
- by striking
or dental medicine curriculumand inserting or dental or podiatric medicine curriculum; and
- in subparagraph (B)—
- (i) in clause (i)—
- by inserting before ; and
- (ii) in clause (ii)—
- by striking
or accredited schooland inserting , an accredited school; and
- by inserting before .
- (b) Effective date
- The amendment made by subsection (a) shall take effect as if enacted on December 29, 2022.